Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants

Clinical trial NCT02745990 · UNKNOWN

Trial details

NCT number: NCT02745990
Sponsor: Huiqing Sun
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Developmental Disabilities

Start date: 2016-05-01
Primary completion: 2022-12-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.